The technicals are going to continue to fly out the window based...

The technicals are going to continue to fly out the window based purely on how quickly IBX can recruit patients for the trial and how well that trial goes. However, the crash in the share price was, as usual, irrational. Not surprising that the tide has turned a bit and the sellers were exhausted.

In my own very personal biased opinion, it was oversold.Still the same company, same potential, with a delay.
The ratio of potential return versus risk is still very steep (which is terrific)... but it's going to require a successful trial to reduce the risk of this opportunity and enable the potential to be realised. If that comes to pass then IBX will be on the path to commercialisation and the "reward" will begin to be priced in... that could be multiples of the current share price.

For now though, risks remain... so the volatility will continue in both directions. We could lose it all. In 3-4 years though?